Antidiabetic effects of fermented soybean products on type 2 diabetes

Nutrition Research

Volumn 30, Issue 1, 2010, Pages 1-13

  Kwon, Dae Young ^a   Daily III, James W ^b   Kim, Hyun Jin ^a   Park, Sunmin ^c  

^a Korea Food Research Institute   (South Korea)

^b Daily Manufacturing Inc   (United States)

^c Hoseo University   (South Korea)

Author keywords

Cell function; Cell mass; Fermented soybean products; Insulin resistance; Isoflavonoids; Peptides; Type 2 diabetes

Indexed keywords

AGLYCONE; DAIDZEIN; GENISTEIN; GLUCOSIDE; INSULIN RECEPTOR SUBSTRATE 2; ISOFLAVONE DERIVATIVE; LUNASIN; SOMATOMEDIN C; SOYBEAN PROTEIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIABETIC DIET; DIET THERAPY; DISEASE COURSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; ESTROGEN ACTIVITY; FERMENTATION; FERMENTED PRODUCT; FOOD COMPOSITION; FOOD INTAKE; FOOD PROCESSING; GASTROINTESTINAL ABSORPTION; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; KOREA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONTENT; REVIEW; SOYBEAN;

ABSORPTION; ANIMALS; BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; FERMENTATION; HUMANS; HYPOGLYCEMIC AGENTS; ISOFLAVONES; PHYTOTHERAPY; PLANT EXTRACTS; SOY FOODS; SOYBEAN PROTEINS; SOYBEANS;

ANIMALIA; GLYCINE MAX;

EID: 74549197901     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.11.004     Document Type: Review

References (113)

1. DeFronzo R.A. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88 (2004) 787-835
2. Kaiser N., and Leibowitz G. Failure of beta-cell adaptation in type 2 diabetes: lessons from animal models. Front Biosci 14 (2009) 1099-1115
3. Weir G.C., and Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53 (2004) S16-S21
4. Butler P.C., Meier J.J., Butler A.E., and Bhushan A. The replication of cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab 3 (2007) 758-768
5. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., and Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
6. Messina M. Soy, soy phytoestrogens (isoflavones), and breast cancer. Am J Clin Nutr 70 (1999) 574-575
7. Davis J., Iqbal M.J., Steinle J., Oitker J., Higginbotham D.A., Peterson R.G., et al. Soy protein influences the development of the metabolic syndrome in male obese ZDFxSHHF rats. Horm Metab Res 37 (2005) 316-325
8. Bhathena S.J., and Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76 (2002) 1191-1201
9. Choi S.B., Jang J.S., and Park S. Estrogen and exercise may enhance beta-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats. Endocrinology 146 (2005) 4786-4794
10. Villegas R., Gao Y.T., Yang G., Li H.L., Elasy T.A., Zheng W., and Shu X.O. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr 87 (2008) 162-167
11. Garcia M.C., Torre M., Marina M.L., and Laborda F. Composition and characterization of soybean and related products. Crit Rev Food Sci Nutr 37 (1997) 361-391
12. Kwon D.Y., Kim S., Kim H.Y.L., and Kim K.S. Changes in physicochemical properties of glycinin due to maleylation. Food Sci Biotechnol 12 (2003) 122-127
13. Kwon D.Y., Oh S.W., Lee J.S., Yang H.J., Lee S.H., Lee J.H., et al. Amino acid substitution of hypocholesterolemic peptide originated from glycinin hydrolyzate. Food Sci Biotechnol 11 (2002) 55-61
14. Young V.R. Soy protein in relation to human protein and amino acid nutrition. J Am Diet Assoc 91 (1991) 828-835
15. Velasquez M.T., and Bhathena S.J. Role of dietary soy protein in obesity. Int J Med Sci 4 (2007) 72-82
16. Murphy P., Song T., Buseman G., Barua K., Beecher G., Trainer D., et al. Isoflavones in retail and institutional soy foods. J Agric Food Chem 47 (1999) 2697-2704
17. Lee Y.W., Kim J.D., Zheng J., and Row K.H. Comparisons of isoflavones from Korean and Chinese soybean and processed products. Biochem Eng J 36 (2007) 49-53
18. Jang C.H., Park C.S., Lim J.K., Kim J.H., Kwon D.Y., Kim Y.S., et al. Metabolism of isoflavone derivatives during manufacturing of traditional meju and doenjang. Food Sci Biotechnol 17 (2008) 442-445
19. Nakajima N., Nozaki N., Ishihara K., Ishikawa A., and Tsuji H. Analysis of isoflavone content in tempeh, a fermented soybean, and preparation of a new isoflavone-enriched tempeh. J Biosci Bioeng 100 (2005) 685-687
20. Yamabe S., Kobayashi-Hattori K., Kaneko K., Endo K., and Takita T. Effect of soybean varieties on the content and composition of isoflavone in rice-koji miso. Food Chem 100 (2007) 369-374
21. Reddy N.R., Piersoon M.D., and Salunkhe D.K. Legume-based fermented foods (1986), CRC Press, Boca Raton 47-118
22. Beak L.M., Park L.Y., Park K.S., and Lee S.H. Effect of starter cultures on the fermentative characteristics of cheonggukjang. Korean J Food Sci Technol 40 (2008) 400-405
23. Park J.S., Lee M.Y., Kim J.S., and Lee T.S. Compositions of nitrogen compound and amino acid in soybean paste (Doenjang) prepared with different microbial sources. Korean J Food Sci Technol 26 (1994) 609-615
24. Sparringa R.A., and Owens J.S. Protein utilization during soybean tempeh fermentation. J Agric Food Chem 47 (1999) 4375-4378
25. Kada S., Yabusaki M., Kaga T., Ashida H., and Yoshida K. Identification of two major ammonia-releasing reactions involved in secondary fermentation. Biosci Biotechnol Biochem 72 (2008) 1869-1876
26. Barnes S., Coward L., Kirk M., and Sfakianos J. HPLC-mass spectrometry analysis of isoflavones. Proc Soc Exp Biol Med 217 (1998) 254-262
27. Choi H.K., Yoon J.H., Kim Y.S., and Kwon D.Y. Metabolomic profiling of cheonggukjang during fermentation by 1H NMR spectrometry and principal components analysis. Process Biochem 42 (2007) 263-266
28. Kim K.S., Kim M.J., Park J.S., Sohn H.S., and Kwon D.Y. Compositions of functional components of traditional Korean soybeans. Food Sci Biotechnol 12 (2003) 157-160
29. Izumi T., Piskula M.K., Osawa S., Obata A., Tobe K., Makoto S., et al. Soy isoflavones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 130 (2000) 1695-1698
30. Lee B.Y., Kim D.M., and Kim K.H. Physico-chemical properties of viscous substance extracted from chungkook-jang. Korean J Food Sci Technol 23 (1991) 599-604
31. Lee K.S., Lee J.C., Lee J.K., Hwang E.S., Lee S.S., and Oh M.J. Quality of 4-recommended soybean cultivars for meju and doenjang. Korean J Food Preserv 9 (2002) 205-211
32. USDA. USDA national nutrient database for standard reference. http://www.nal.usda.gov/fnic/foodcomp/search/
33. 1H nuclear magnetic resonance spectroscopy and principal component analysis. Biosci Biotechnol Biochem 73 (2009) 502-507
34. Piskula M.K., Yamakoshi J., and Yukihiko I. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Letters 447 (1999) 287-291
35. Wang H.J., and Murphy P.A. Isoflavone content in commercial soybean foods. J Agric Food Chem 42 (1994) 1666-1673
36. King R.A., Broadbent J.L., and Head R.J. Absorption and excretion of the soy isoflavones genistein in rats. J Nutr 126 (1996) 176-182
37. Zubik L., and Meydani M. Bioavailability of soybean isoflavones from aglycones and glucoside forms in American women. Am J Clin Nutr 77 (2003) 1459-1465
38. Rüfer C.E., Bub A., Möseneder, Winterhalter P., Störtz M., and Kulling S.E. Pharmacokinetis of the soybean isoflavones daidzein in its aglycones and glucoside form: a randomized, double-blind, crossover study. Am J Clin Nutr 87 (2008) 1314-1323
39. Gardner C.D., Chatterjee L.M., and Franke A.A. Effects of isoflavones supplements vs. soy foods on blood concentrations of genistein and daidzein in adults. J Nutr Biochem 20 (2008) 227-234
40. Xia X., Wang H.J., Murphy P.A., and Hendrich S. Neither background diet nor type of soy food affects short-term isoflavones bioavailability in women. J Nutr 130 (2000) 798-801
41. Chanteranne B., Branca F., Kaardinal A., Braesco V., Ladroite P., Brouns F., et al. Food matrix and isoflavones bioavailability in early post menopausal: a clinical European study. Clin Interv Aging 3 (2008) 711-718
42. Setchell K.D., Brown N.M., Desai P.B., Zimmer-Nechimias L., Wolfe B., Jakate A.S., et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133 (2003) 1027-1035
43. Vergne S., Bennetau-Pelissero C., Lamothe V., Chantre P., Potier M., Asselineau J., et al. Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young health males. Br J Nutr 99 (2008) 333-344
44. Raimondi S., Roncaglia L., De Lucia M., Amaretti A., Leonardi A., Pagoni U.M., et al. Bioconversion of soy isoflavones daidzin and daidzein by Bifobacterium strains. Appl Microbiol Biotechnol 81 (2009) 943-950
45. Xu X., Harris K.S., Wang H.J., Murphy P.A., and Hendrich S. Bioavailability of soybean isflavones depends upon gut microflora in women. J Nutr 125 (1995) 2307-2315
46. Nielsen I.L.F., and Williamson G. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer 57 (2007) 1-10
47. Fujioka M., Uehara M., Wu J., Adlercreutz H., Suzuki K., Kanazawa K., et al. Equol, a metabolit of daidzein, inhibits bone loss in ovariectomized mice. J Nutr 134 (2004) 2623-2627
48. Gonzalez S., Jayagopal V., Kilpatrick E.S., Chapman T., and Atkin S.L. Effects of isoflavones dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care 30 (2007) 1871-1873
49. Setchell K.D.R., Brown N.M., and Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy isflavones. J Nutr 132 (2002) 3577-3584
50. Halm B.M., Ashburn L.S., and Franke A.A. Isoflavones from soya foods are more bioavailable in children than adults. Br J Nutr 98 (2007) 998-1005
51. Franke A.A., Halm B.M., and Ashburn L.A. Isoflavones in children and adults consuming soy. Arch Biochem Biophys 15 (2008) 161-170
52. Lioe H.N., Apriyantono A., Takara K., Wada K., Naoik H., and Yasuda M. Low molecular weight compounds responsible for savory taste of Indonesian soy sauce. J Agric Food Chem 52 (2004) 5950-5956
53. Aaslyng M.D., Martens M., Poll L., Nielsen P.M., Flyge H., and Larsen L.M. Chemical and sensory characterization of hydrolyzed vegetable protein, a savory flavoring. J Agric Food Chem 46 (1998) 481-489
54. Sites C.K., Cooper B.C., Toth M.J., Gastaldelli A., Arabshahi A., and Barnes S. Effect of daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. Fertil Steril 88 (2007) 1609-1617
55. Galvez A.F., Chen N., Macasieb J., and de Lumen B.O. Chemopreventive property of a soybean peptide (Lunasin) that binds to deacetylated histones and inhibits acetyation. Cancer Res 61 (2001) 7473-7478
56. Park J.H., Jeong H.J., and Lumen B.O. In vitro digestibility of the cancer-preventive soy peptides lunasin and BBI. J Agric Food Chem 55 (2007) 10703-10706
57. Mejia E.G., and Dia V.P. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappaB pathway in the macrophage. Peptides (2009) [online publication]
58. Inoue K., Gotou T., Kitajima H., Mizuno S., Nakazawa T., and Yamamoto N. Release of antihypertensive peptides in miso paste during its fermentation, by the addition of casein. J Biosci Bioeng 108 (2009) 111-115
59. Kim S.H., Lee Y.J., and Kwon D.Y. Isolation of angiotensin converting enzyme inhibitor from doenjang. Korean J Food Sci Technol 31 (1999) 848-854
60. Shimizu M., and Son D.O. Food-derived peptides and intestinal functions. Curr Pharm Design 13 (2007) 885-895
61. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M., Previs S., et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 (1998) 900-904
62. Milburn Jr. J.L., Hirose H., Lee Y.H., Nagasawa Y., Ogawa A., Ohneda M., et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 270 (1995) 1295-1299
63. Hirose H., Lee Y.H., Inman L.R., Nagasawa Y., Johnson J.H., and Unger R.H. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem 271 (1996) 5633-5637
64. Kulkarni R.N., Jhala U.S., Winnay J.N., Krajewski S., Montminy M., and Kahn C.R. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 114 (2004) 828-836
65. González C., Alonso A., Grueso N.A., Díaz F., Esteban M.M., Fernández S., et al. Effect of treatment with different doses of 17β-estradiol on insulin receptor substrate-1. J Pancreas 2 (2001) 140-149
66. Zethelius B., Hales C.N., Lithell H.O., and Berne C. Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care 27 (2004) 1433-1438
67. Brussaard H.E., Gevers Leuven J.A., Frolich M., Kluft C., and Krans H.M. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40 (1997) 843-849
68. Espeland M.A., Hogan P.E., Fineberg S.E., Howard G., Schrott H., Waclawiw M.A., et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 21 (1998) 1589-1595
69. Brown M.D., Korytkowski M.T., Zmuda J.M., McCole S.D., Moore G.E., and Hagberg J.M. Insulin sensitivity in postmenopausal women. Diabetes Care 23 (2000) 1731-1736
70. Ryan A.S., Nicklas B.J., and Berman D.M. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 25 (2002) 127-133
71. Ferrannini E., Camastra S., Gastaldelli A., Maria Sironi A., Natali A., Muscelli E., et al. Beta-cell function in obesity: effects of weight loss. Diabetes 53 (2004) S26-33
72. Kimura M., Irahara M., Yasui T., Saito S., Tezuka M., Yamano S., et al. The obesity in bilateral ovariectomized rats is related to a decrease in the expression of leptin receptors in the brain. Biochem Biophys Res Comm 290 (2002) 1349-1353
73. Burguera B., Hofbauer L.C., Thomas T., Gori F., Evans G.L., Khosla S., et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142 (2001) 3546-3553
74. Simkin-Silverman L.R., and Wing R.R. Weight gain during menopause: is it inevitable or can it be prevented?. Postgrad Med J 108 (2000) 47-50
75. Sutter-Dub M. Preliminary report: effects of female sex hormones on insulin secretion by the perfused rat pancreas. J Physiol Paris 72 (1976) 795-800
76. Nadal J., Rovira M., Laribi O., Leon-Quinto T., Andreu E., Ripoll C., et al. Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J 12 (1998) 1341-1348
77. Ropero A.B., Fuentes E., Rovira J.M., Ripoll C., Soria B., and Nadal A. Non-genomic actions of 17β-oestradiol in mouse pancreatic β-cells are mediated by a cGMP-dependent protein kinase. J Physiol (Lond) 521 (1999) 397-407
78. White M.F. The IRS-signaling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182 (1998) 3-11
79. Jhala U.S., Canettieri G., Screaton R.A., Kulkarni R.N., Krajewski S., Reed J., et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17 (2003) 1575-1580
80. Mezei O., Banz W.J., Steger R.W., Peluso M.R., Winters T.A., and Shay N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133 (2003) 1238-1243
81. Ishihara K., Oyaizu S., Fukuchi Y., Mizunoya W., Segawa K., Takahashi M., et al. A soybean peptide isolate diet promotes postprandial carbohydrate oxidation and energy expenditure in type II diabetic mice. J Nutr 133 (2003) 752-757
82. Sites C.K., Cooper B.C., Toth M.J., Gastaldelli A., Arabshahi A., and Barnes S. Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. Fertil Steril 88 (2007) 1609-1617
83. González S., Jayagopal V., Kilpatrick E.S., Chapman T., and Atkin S.L. Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care 30 (2007) 1871-1873
84. Knight D.C., and Eden J.A. A review of the clinical effects of phytoestrogens. Obstet Gynecol 87 (1996) 897-904
85. Kuiper G.G.J.M., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139 (1998) 4252-4263
86. Murkies A.L., Wilcox G., and Davis S.R. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab 83 (1998) 297-303
87. Lemieux C., Gélinas Y., Lalonde J., Labrie F., Richard D., and Deshaies Y. The selective estrogen receptor modulator acolbifene reduces cholesterolemia independently of its anorectic action in control and cholesterol-fed rats. J Nutr 135 (2005) 2225-2229
88. Pipe E.A., Gobert C.P., Capes S.E., Darlington G.A., Lampe J.W., and Duncan A.M. Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes. J Nutr 139 (2009) 1700-1706
89. Nordentoft I., Jeppesen P.B., Hong J., Abudula R., and Hermansen K. Increased insulin sensitivity and changes in the expression profile of key insulin regulatory genes and beta cell transcription factors in diabetic KKAy-mice after feeding with a soy bean protein rich diet high in isoflavone content. J Agric Food Chem 56 (2008) 4377-4385
90. Azadbakht L., Atabak S., and Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 31 (2008) 648-654
91. Trujillo J., Ramírez V., Pérez J., Torre-Villalvazo I., Torres N., Tovar A.R., et al. Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol 288 (2005) F108-116
92. Teixeira S.R., Tappenden K.A., Carson L., Jones R., Prabhudesai M., Marshall W.P., et al. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134 (2004) 1874-1880
93. Lu M.P., Wang R., Song X., Chibbar R., Wang X., Wu L., et al. Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats. Nutr Res 28 (2008) 464-471
94. Cederroth C.R., Vinciguerra M., Gjinovci A., Kühne F., Klein M., Cederroth M., et al. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57 (2008) 1176-1185
95. Nikander E., Tiitinen A., Laitinen K., Tikkanen M., and Ylikorkala O. Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women. J Clin Endocrinol Metab 89 (2004) 3567-3572
96. Clifton-Bligh P.B., Baber R.J., Fulcher G.R., Nery M.L., and Moreton T. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 8 (2001) 259-265
97. Goodman-Gruen D., and Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131 (2001) 1202-1206
98. Noriega-López L., Tovar A.R., Gonzalez-Granillo M., Hernández-Pando R., Escalante B., Santillán-Doherty P., et al. Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J Biol Chem 282 (2007) 20657-20666
99. Ronis M.J., Chen Y., Badeaux J., and Badger T.M. Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr 139 (2009) 1431-1438
100. Veloso R.V., Latorraca M.Q., Arantes V.C., Reis M.A., Ferreira F., Boschero A.C., et al. Soybean diet improves insulin secretion through activation of cAMP/PKA pathway in rats. J Nutr Biochem 19 (2008) 778-784
101. Taniguchi A., Yamanaka-Okumura H., Nishida Y., Yamamoto H., Taketani Y., and Takeda E. Natto and viscous vegetables in a Japanese style meal suppress postprandial glucose and insulin responses. Asia Pac J Clin Nutr 17 (2008) 663-668
102. Kwon D.Y., Hong S.M., Ahn I.S., Kim Y.S., Shin D.W., and Park S. Kochujang, a Korean fermented red pepper plus soybean paste, improves glucose homeostasis in 90% pancreatectomized diabetic rats. Nutrition 25 (2009) 790-799
103. Kawakami Y., Tsurugasaki W., Nakamura S., and Osada K. Comparison of regulative functions between dietary soy isoflavones aglycone and glucoside on lipid metabolism in rats fed cholesterol. J Nutr Biochem 16 (2005) 205-212
104. Kwon D.Y., Jang J.S., Hong S.M., Lee J.E., Sung S.R., Park H.R., et al. Long-term consumption of fermented soybean-derived Chungkookjang enhances insulinotropic action unlike soybeans in 90% pancreatectomized diabetic rats. Eur J Nutr 46 (2007) 44-52
105. Kwon D.Y., Hong S.M., Lee J.E., Sung S.R., and Park S. Long-term consumption of fermented soybean-derived Chungkookjang attenuates hepatic insulin resistance in 90% pancreatectomized diabetic rats. Horm Metab Res 39 (2007) 752-757
106. Fujita H., and Yamagami T. Fermented soybean-derived Touchi-extract with anti-diabetic effect via alpha-glucosidase inhibitory action in a long-term administration study with KKAy mice. Life Sci 70 (2001) 219-227
107. Fujita H., Yamagami T., and Ohshima K. Long-term ingestion of a fermented soybean-derived Touchi-extract with alpha-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetes. J Nutr 131 (2001) 2105-2108
108. Kim D.J., Jeong Y.J., Kwon J.H., Moon K.D., Kim H.J., Jeon S.M., et al. Beneficial effect of chungkukjang on regulating blood glucose and pancreatic beta-cell functions in C75BL/KsJ-db/db mice. J Med Food 11 (2008) 215-223
109. Kwon D.Y., Jang J.S., Lee J.E., Kim Y.S., Shin D.W., and Park S. The isoflavonoid aglycone-rich fractions of Chungkookjang, fermented unsalted soybeans, enhance insulin signaling and peroxisome proliferator-activated receptor-γ activity in vitro. Biofactors 26 (2006) 245-258
110. Jung K.O., Park S.Y., and Park K.Y. Longer aging time increases the anticancer and antimetastatic properties of doenjang. Nutrition 22 (2006) 539-545
111. Karlsson S., Scheurink A.J., Steffens A.B., and Ahrén B. Involvement of capsaicin-sensitive nerves in regulation of insulin secretion and glucose tolerance in conscious mice. Am J Physiol 267 (1994) R1071-R1077
112. Diepvens K., Westerterp K.R., and Westerterp-Plantenga M.S. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol 292 (2007) R77-85
113. Choi Y.M., and Suh H.J. Pharmacological effects of fermented red pepper. Phytother Res 18 (2004) 884-888